InvestorsHub Logo
Followers 2
Posts 4
Boards Moderated 0
Alias Born 05/06/2022

Re: None

Wednesday, 07/02/2025 4:20:32 PM

Wednesday, July 02, 2025 4:20:32 PM

Post# of 437305
Hi everyone,

I wanted to share a deep dive I put together analyzing the current status of Hikma v. Amarin at the Supreme Court level and the likelihood of the Solicitor General supporting certiorari. It walks through the legal pathway, strategic implications, and potential impact on Amarin's value and positioning, especially in light of recent retail and legal community engagement (e.g., north40000's filings and Hazel-Atlas references). It analyzed all available legal documents I uploaded in the past year leading up to where we currently sit with the SG.

📄 Memo Title:
SCOTUS Analysis of Hikma v. Amarin and SG Certiorari Outlook

🔗 Link to Full Memo:
https://chatgpt.com/s/dr_685f825292dc8191851738b7cb8bbc36

Would love to hear the board's take, especially on how you all view the SG’s potential stance, the fraud angle that’s been raised, and what it could mean for AMRN's leverage in 2025.

Note: Please disregard the memo letterhead at the top. It was unintentionally formatted as a formal internal memorandum addressed to Amarin Pharma. The content that follows is an independent legal analysis prepared for discussion and strategic insight, not an internal company document.

If you guys like the format, I have many others prepared on various Amarin topics that you might find interesting or informative. Happy to share weekly.

— San Diego living
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News